Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Berberine as Adjuvant Treatment for Schizophrenia Patients (BER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02983188
Recruitment Status : Recruiting
First Posted : December 6, 2016
Last Update Posted : May 20, 2019
Sponsor:
Collaborators:
Queen Mary Hospital, Hong Kong
Kowloon Hospital, Hong Kong
Castle Peak Hospital
Zhejiang Provincial Tongde Hospital
Information provided by (Responsible Party):
Prof. Zhang Zhang-Jin, The University of Hong Kong

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : October 2019
  Estimated Study Completion Date : October 2020
Publications: